Get the Stockscreener App
18.62
3.10%
0.56
Pre-market:
18.85
0.23
+1.24%
Tonix Pharmaceuticals Holding Corp stock is traded at $18.62, with a volume of 411.95K.
It is up +3.10% in the last 24 hours and down -22.93% over the past month.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$18.06
Open:
$18.18
24h Volume:
411.95K
Relative Volume:
0.32
Market Cap:
$163.22M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-1.6536
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
-4.46%
1M Performance:
-22.93%
6M Performance:
+3.39%
1Y Performance:
+28.15%
1-Day Range:
$17.99
$18.74
1-Week Range:
$17.99
$20.58
52-Week Range:
$7.31
$130.00
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Name
Tonix Pharmaceuticals Holding Corp
Sector
Industry
Phone
212-980-9155
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Compare TNXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
18.62 | 207.25M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-18-22 | Initiated | Noble Capital Markets | Outperform |
| Apr-18-19 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-18-17 | Upgrade | ROTH Capital | Neutral → Buy |
| Sep-07-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-17-16 | Reiterated | Oppenheimer | Outperform |
| Nov-04-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-12-15 | Initiated | Oppenheimer | Outperform |
| Feb-17-15 | Reiterated | ROTH Capital | Buy |
| Sep-29-14 | Reiterated | ROTH Capital | Buy |
View All
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
Can Tonix Pharmaceuticals Holding Corp. stock deliver strong Q4 earningsEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
How to build a dashboard for Tonix Pharmaceuticals Holding Corp. stockJuly 2025 Big Picture & Trade Opportunity Analysis - newser.com
Volatility clustering patterns for Tonix Pharmaceuticals Holding Corp.Quarterly Portfolio Report & Long-Term Capital Growth Strategies - newser.com
Will Tonix Pharmaceuticals Holding Corp. stock deliver strong dividend growthPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
Will Tonix Pharmaceuticals Holding Corp. stock deliver shareholder valueEarnings Recap Summary & AI Driven Stock Movement Reports - newser.com
Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.Quarterly Trade Review & Entry and Exit Point Strategies - newser.com
Tonix Pharmaceuticals Holding Corp. stock trend forecastQuarterly Market Summary & Daily Price Action Insights - newser.com
Real time alert setup for Tonix Pharmaceuticals Holding Corp. performanceJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - newser.com
What drives Tonix Pharmaceuticals Holding Corp stock priceMarket Sentiment Report & Exceptional Return Stocks - earlytimes.in
Tonix Pharmaceuticals Holding Corp. (TNXP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Tonix Pharmaceuticals Holding Corp. (TNXP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Tonix Pharmaceuticals Holding Corp. stock trading at a premium valuationGap Down & Verified Stock Trade Ideas - newser.com
Is Tonix Pharmaceuticals Holding Corp. stock a safe haven assetQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
How to recover losses in Tonix Pharmaceuticals Holding Corp. stockJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
Tonix Pharma. Holding Corp. R (TPM0.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tonix Pharmaceuticals Holding Corp (TNXP) Showcases Promising TNX-801 Vaccine Data - Insider Monkey
Top 8 Long-Term Biotechnology Stocks to Buy - Insider Monkey
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025 - The Manila Times
Tonix Pharmaceuticals (NASDAQ: TNXP) to present at BIO-Europe 2025; Vienna session Nov 4 - Stock Titan
What dividend safety score for Tonix Pharmaceuticals Holding Corp. stockWeekly Trading Summary & Comprehensive Market Scan Insights - fcp.pa.gov.br
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):